Skip to main content
logo
Telomir Pharmaceuticals logo
Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
1.110
-0.040 (-3.48%)
Oct 9, 2026, 2:13 PM EDT - Market open

Telomir Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
8246123---
Market Cap Growth
34.19%-62.70%----
Enterprise Value
7738122---
Last Close Price
1.151.334.12---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
15.717.73190.63---
P/TBV Ratio
16.827.73190.63---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.030.080.140.18-0.62-0.86
Net Debt / Equity Ratio
-1.00-1.15-1.820.18-0.62-0.86
Quick Ratio
15.555.101.860.000.00-
Current Ratio
16.145.141.940.330.05-
Return on Equity (ROE)
-213.10%-317.65%-810.18%-1045.36%--
Return on Assets (ROA)
-122.81%-152.03%-250.96%-102.18%--
Return on Capital Employed (ROCE)
-120.90%-178.20%-1903.80%-114.70%91.10%100.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-61.41%-22.77%-13.49%---
Buyback Yield / Dilution
-34.76%-7.16%-8.18%-1.77%--
SEC Filings: 10-K · 10-Q